
FDA finalizes guidance on written responses and meeting types
October 12, 2026



Celloram develops cancer vaccine using COVID immune memory to activate T cells against tumors in mice.
Apixaban may cut stroke risk in kidney patients with atrial fibrillation and chronic kidney disease.